openPR Logo
Press release

Weitz & Luxenberg Wins $25 Million in Mesothelioma Verdict

11-30-2006 11:49 AM CET | Politics, Law & Society

Press release from: Weitz & Luxenberg

One of the leading plaintiffs, mass torts, product liability, and personal injury litigation law firms in America.

One of the leading plaintiffs, mass torts, product liability, and personal injury litigation law firms in America.

November 29, 2006, New York, NY—In its ongoing effort to hold corporations responsible for recklessly exposing workers to the lethal toxin asbestos, Weitz & Luxenberg, P.C. obtained a jury verdict ordering DaimlerChrysler AG to pay $25 million to a New York City brake reliner who lost his right lung to mesothelioma, a rare cancer caused by asbestos.

Chrysler, the world’s fifth-largest automaker, was found to have acted in “reckless disregard for the safety of others,” in its failure to warn of the hazards of asbestos, which it has known about since the 1930’s. The case (Index no. 113939/04, New York Supreme Court, Manhattan) was brought by Alfred D’Ulisse, 73 and his wife, Margaret, of North Massapequa, New York. Mr. D’Ulisse, a retired police officer, was exposed to asbestos while relining Chrysler brakes at Morak Brakes in Brooklyn, New York, from 1960 to 1981.

Michael Roberts, Weitz & Luxenberg trial team attorney said, “The jury obviously disbelieved Chrysler’s bogus litigation-defense that working with asbestos brakes is safe.”

The Weitz & Luxenberg trial team included Roberts, Adam Cooper and Jerry Kristal, with additional support by associate attorney Patti Burshtyn. Prior to this case, Chrysler had boasted of winning 14 asbestos-related cases in a row. In this suit, Chrysler was found to be “jointly and severally liable,” thus requiring the company to pay 80 percent of the verdict—its 10 percent share and an additional 70 percent for the shares of two other companies. This is believed to be the highest verdict against Chrysler, to date.

Weitz & Luxenberg is known for spearheading asbestos cases, among others, winning a historic consolidated trial in 1991 involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s. Weitz & Luxenberg represented 36 clients in that case and secured verdicts of $75 million. In 1996, Weitz & Luxenberg obtained a $64.65 million award for four asbestos plaintiffs and in 2002, the firm won a $53 million verdict for a brake mechanic suffering from mesothelioma. The firm has recovered hundreds of millions more for its clients, many of whom formed the backbone of the victorious Allied war effort in World War II.

Most people who develop mesothelioma have worked on jobs where they inhaled asbestos particles. Weitz & Luxenberg represents numerous individuals who have serious injuries related to asbestos. These injuries include mesothelioma, lung cancer, asbestosis (a noncancerous, chronic lung ailment), and other cancers, such as those of the larynx and kidney.

People who have been injured by asbestos can contact Weitz & Luxenberg. Interested parties should call the Client Relations department at 1 (800) 476-6070 or via e-mail by writing to Please also visit our website at

David Kufeld
Weitz & Luxenberg
180 Maiden Lane
New York, NY

About Weitz & Luxenberg, P.C.:
Weitz & Luxenberg, founded in 1986, is one of the leading plaintiffs, mass torts, product liability, and personal injury litigation law firms in America. The firm has played leading roles in national and local litigations involving asbestos, DES, silicone breast implants, medical malpractice, and general negligence, among others. A forerunner in the legal fight against environmental polluters, Weitz & Luxenberg has worked with clients harmed by MTBE and mercury, among other toxins. The firm has won numerous cases involving dangerous pharmaceuticals, including Vioxx, achieving a $13.5 million verdict against Merck & Co. (docket No. ATLL129605). It also recently filed a case related to the harmful acne medicine, Accutane, manufactured by Hoffman-La Roche Inc. (State Supreme Court of New Jersey, May 2, 2006, Mass Tort general docket No. 271). The firm’s other active pharmaceutical litigations include actions against the manufacturers of Bextra, Celebrex, Ortho Evra and Seroquel.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Weitz & Luxenberg Wins $25 Million in Mesothelioma Verdict here

News-ID: 13297 • Views:

More Releases from Weitz & Luxenberg

Weitz & Luxenberg Cited for Top NYS 2014 Product Liability Cases by New York Law …
Weitz & Luxenberg, P.C. has been recognized by the New York Law Journal for winning the top three product liability verdicts in New York State in 2014. “The lawyers and law firms who are ranked in this special section represent the best of the best in 2014,” New York Law Journal associate publisher Farrell McManus wrote in the Journal’s “Top Verdicts New York 2014.” He continued, “Their zealous advocacy on
Mesothelioma Treatment Tomudex Receives International Support
Mesothelioma Treatment Tomudex Receives International Support
Mesothelioma treatment Tomudex, made by a global pharmaceutical company, is receiving approval from a panel of international experts. Tomudex falls in the group of anti-cancer drugs known as antineoplastics. It prevents cell growth. By doing so, it leads to the elimination of tumors. In a study examining people diagnosed with pleural mesothelioma, the use of Tomudex in conjunction with Platinol resulted in improved response rates of 23.6% as opposed to
New Mesothelioma Treatment Technique Developed
New Mesothelioma Treatment Technique Developed
Extrapleural pneumonectomy, a surgical procedure that removes mesothelioma cancer from the lining of the lung, has been reported to be an effective new mesothelioma treatment technique. The technique was developed by Dr. Sugarbaker, the co-leader of the Brigham Biomedical Research Institute's Cancer Research Center, Chief of the Institute's Division of Thoracic Surgery and a Professor of Oncologic Surgery at Harvard Medical School. The surgical technique was applied on a mesothelioma patient
Mesothelioma Cancer: Possible Treatment Option
Mesothelioma Cancer: Possible Treatment Option
An experiment carried out in Memorial Sloan-Kettering Cancer Center, Mount Sinai School of Medicine and the Medical University Vienna has tested the effectiveness of a genetically modified virus to treat mesothelioma in animals. The virus is known as Newcastle Disease Virus (NDV). Animals with mesothelioma administered with multiple doses of NDV responded better than those that received a single dose. The use of a genetically engineered virus to disrupt the function

All 5 Releases

More Releases for Chrysler

Reliance Chrysler Dodge Jeep Ram Speaks About Their Jeep SUV
The Jeep brand incorporates the essence of rugged and versatile vehicles. Jeeps have a long history of building customer loyalty because of reliability, fuel economy, comfort, and internal fit and finish. Talking to Reliance Chrysler Dodge Jeep Ram shows Jeep fans described the brand as high quality, practical, good value for money, classic, and well made. Jeep Wrangler, Grand Cherokee, and Cherokee are among America's 10 Most Popular Vehicles. If you're regularly
Connected Vehicles Market 2020-2026 :BMW, Broadcom, Chrysler, Benz
Global Connected Vehicles Market Research Report 2020-2026, this title divided by product type, applications, industry verticals, and research regions build an in-depth explanation of the perspectives, and comprehensive market statistics. The report presents a thorough analysis of the Connected Vehicles Market covering key trends, deployment models, challenges, market drivers, future roadmap, ecosystem player profiles, strategies, and value chain. Click the link to get a free Sample Copy of the Report (before
Global Connected Vehicles Market 2018 - BMW, Broadcom, Chrysler, Benz, Daimler
Apex Market Reports, recently published a detailed market research study focused on the “Connected Vehicles Market” across the global, regional and country level. The report provides 360° analysis of “Connected Vehicles Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Connected Vehicles on
Chrysler Bidder Imperato To Support Workers at Employee Buyout Demonstration
Detroit, MI – 6/1/07 Today Chrysler Bidder Daniel Imperato endorsed the workers movement at the Chrysler Corporation and the Chrysler Employee Owned Buyout Committee. Imperato who had originally proposed an ESOP (Employee Stock Ownership Plan) for the workers of Chrysler has now placed his backing behind the employee committee, headed by Michele Mauder. To his support, Imperato will be attending a worker\'s rally this Monday at Chrysler Headquarters in Auburn Hills. \"I\'m
Chrysler Employee Group Follows Imperato's Advice and Bids on Chrysler
Detroit – In a formal letter to DaimlerChrysler AG Chairman and CEO Dieter Zetsche, 25 employees from the local Chrysler Jeep manufacturing plan in Toledo, Ohio submitted a bid for the United Auto Workers to acquire the Chrysler Corporation. The committee named the \"Chrysler Employee Buyout Committee\", led by Michele Mauder, has proposed an employee stock ownership plan or (ESOP) in exchange for healthcare concessions. The proposal comes
Chrysler: Saving A Great Automaker, or Breakup Deal?
Labor Union Friendly Bids Left Out in Favor of Private Equity Buyouts As DaimlerChrysler AG Executive and Board Member, Rüdiger Grube, meets with prospective buyers this week at JP Morgan Chase offices in New York, it appears that two more union-friendly proposals have been left out of those meetings. Grube is scheduled today to start a week long round of meetings with representatives from the tandem of Blackstone Group and Centerbridge